Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Introduction

Introduction This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Dermatologists have long noted the need for a systemically administered drug designed to combat superficial infections of the skin due to fungi. Griseofulvin is the first such agent; its development appears to be assuming proportions of an historic nature. In October, 1959, the Department of Dermatology of the University of Miami School of Medicine, through a grant from McNeil Laboratories, Inc., subsidiary of Johnson & Johnson, conducted a symposium on griseofulvin which was international in scope. Investigators from eleven countries reported on their experiences with the drug. Because of the widespread interest in the subject, this issue of the Archives is devoted entirely to the proceedings of that symposium. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Dermatology American Medical Association

Introduction

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Dermatologists have long noted the need for a systemically administered drug designed to combat superficial infections of the skin due to fungi. Griseofulvin is the first such agent; its development appears to be assuming proportions of an historic nature. In October, 1959, the Department of Dermatology of the University of Miami School of Medicine,...
Loading next page...
 
/lp/american-medical-association/introduction-GKRzK1mqNo

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1960 American Medical Association. All Rights Reserved.
ISSN
0096-5359
DOI
10.1001/archderm.1960.03730050005001
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Dermatologists have long noted the need for a systemically administered drug designed to combat superficial infections of the skin due to fungi. Griseofulvin is the first such agent; its development appears to be assuming proportions of an historic nature. In October, 1959, the Department of Dermatology of the University of Miami School of Medicine, through a grant from McNeil Laboratories, Inc., subsidiary of Johnson & Johnson, conducted a symposium on griseofulvin which was international in scope. Investigators from eleven countries reported on their experiences with the drug. Because of the widespread interest in the subject, this issue of the Archives is devoted entirely to the proceedings of that symposium.

Journal

A.M.A. Archives of DermatologyAmerican Medical Association

Published: May 1, 1960

There are no references for this article.